mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for MAPK11
Gene summary
Basic gene Info.Gene symbolMAPK11
Gene namemitogen-activated protein kinase 11
SynonymsP38B|P38BETA2|PRKM11|SAPK2|SAPK2B|p38-2|p38Beta
CytomapUCSC genome browser: 22q13.33
Type of geneprotein-coding
RefGenesNM_002751.6,
NR_110887.1,
DescriptionMAP kinase 11MAP kinase p38 betamitogen-activated protein kinase p38 betamitogen-activated protein kinase p38-2stress-activated protein kinase-2stress-activated protein kinase-2b
Modification date20141222
dbXrefs MIM : 602898
HGNC : HGNC
Ensembl : ENSG00000185386
HPRD : 04208
Vega : OTTHUMG00000150226
ProteinUniProt: Q15759
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_MAPK11
BioGPS: 5600
PathwayNCI Pathway Interaction Database: MAPK11
KEGG: MAPK11
REACTOME: MAPK11
Pathway Commons: MAPK11
ContextiHOP: MAPK11
ligand binding site mutation search in PubMed: MAPK11
UCL Cancer Institute: MAPK11
Assigned class in mutLBSgeneDBB: This gene belongs to targetable_mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID
GO:0006950response to stress8663524
GO:0035556intracellular signal transduction8663524


Top
Ligand binding site mutations for MAPK11

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
H148R149WBLCA1
L167L167MLUAD1
V52V52MSKCM1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for MAPK11
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
L167L167M-1.6732182
V52V52M-1.143558
H148R149W-0.25963597
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for MAPK11 from PDB

Top
Differential gene expression and gene-gene network for MAPK11
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of MAPK11 and the right PPI network was created from samples without mutations in the LBS of MAPK11. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for MAPK11
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type
umls:C0878544Cardiomyopathies1Therapeutic

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for MAPK11
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.

Gene-centered drug-gene interaction network
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure
InvestigationalDB05157KC706Small molecule
ApprovedDB08896RegorafenibSmall molecule

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of MAPK11 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
NILNILOTINIB3gp0AH148 L167
B455-(2-CHLORO-4-FLUOROPHENYL)-1-(2,6-DICHLOROPHENYL)-7-[1-(1-METHYLETHYL)PIPERIDIN-4-YL]-3,4-DIHYDROQUINAZOLIN-2(1H)-ONE3gc8AV52 L167
B455-(2-CHLORO-4-FLUOROPHENYL)-1-(2,6-DICHLOROPHENYL)-7-[1-(1-METHYLETHYL)PIPERIDIN-4-YL]-3,4-DIHYDROQUINAZOLIN-2(1H)-ONE3gc8BV52 L167
B455-(2-CHLORO-4-FLUOROPHENYL)-1-(2,6-DICHLOROPHENYL)-7-[1-(1-METHYLETHYL)PIPERIDIN-4-YL]-3,4-DIHYDROQUINAZOLIN-2(1H)-ONE3gc9AV52 L167
B455-(2-CHLORO-4-FLUOROPHENYL)-1-(2,6-DICHLOROPHENYL)-7-[1-(1-METHYLETHYL)PIPERIDIN-4-YL]-3,4-DIHYDROQUINAZOLIN-2(1H)-ONE3gc9BV52 L167


Top
Conservation information for LBS of MAPK11
Multiple alignments for Q15759 in multiple species
LBSAA sequence# speciesSpecies
A111TTLMGADLNNI2Homo sapiens, Mus musculus
A111NELMEFDLYRT1Arabidopsis thaliana
A157KPSNVAVNEDC2Homo sapiens, Mus musculus
A157KPSNLLLSTQC1Arabidopsis thaliana
A34PVGSGAYGSVC2Homo sapiens, Mus musculus
A34PIGRGACGIVC1Arabidopsis thaliana
A51LRQKVAVKKLS2Homo sapiens, Mus musculus
A51TNEKVAIKKIT1Arabidopsis thaliana
D292RMLVLDSDQRV2Homo sapiens, Mus musculus
D292KMLTFDPKQRI1Arabidopsis thaliana
D294LVLDSDQRVSA2Homo sapiens, Mus musculus
D294LTFDPKQRISV1Arabidopsis thaliana
E245GTPSPEVLAKI2Homo sapiens, Mus musculus
E245GTPSEEELGSL1Arabidopsis thaliana
E71RRTYRELRLLK2Homo sapiens, Mus musculus
E71KRTLREIKLLR1Arabidopsis thaliana
G110VTTLMGADLNN2Homo sapiens, Mus musculus
G110VNELMEFDLYR1Arabidopsis thaliana
H148SAGIIHRDLKP2Homo sapiens, Mus musculus
H148SANVLHRDLKP1Arabidopsis thaliana
I84KHENVIGLLDV2Homo sapiens, Mus musculus
I84DHENIVAIRDV1Arabidopsis thaliana
K53QKVAVKKLSRP2Homo sapiens, Mus musculus
K53EKVAIKKITQV1Arabidopsis thaliana
L104FSEVYLVTTLM2Homo sapiens, Mus musculus
L104FEDVYIVNELM1Arabidopsis thaliana
L108YLVTTLMGADL2Homo sapiens, Mus musculus
L108YIVNELMEFDL1Arabidopsis thaliana
L167CELRILDFGLA2Homo sapiens, Mus musculus
L167CDLKICDFGLA1Arabidopsis thaliana
L74YRELRLLKHLK2Homo sapiens, Mus musculus
L74LREIKLLRHFD1Arabidopsis thaliana
L75RELRLLKHLKH2Homo sapiens, Mus musculus
L75REIKLLRHFDH1Arabidopsis thaliana
M109LVTTLMGADLN2Homo sapiens, Mus musculus
M109IVNELMEFDLY1Arabidopsis thaliana
N155DLKPSNVAVNE2Homo sapiens, Mus musculus
N155DLKPSNLLLST1Arabidopsis thaliana
R67LIHARRTYREL2Homo sapiens, Mus musculus
R67TIEAKRTLREI1Arabidopsis thaliana
S154RDLKPSNVAVN2Homo sapiens, Mus musculus
S154RDLKPSNLLLS1Arabidopsis thaliana
T106EVYLVTTLMGA2Homo sapiens, Mus musculus
T106DVYIVNELMEF1Arabidopsis thaliana
T107VYLVTTLMGAD2Homo sapiens, Mus musculus
T107VYIVNELMEFD1Arabidopsis thaliana
V30-GLRPVGSGAY2Homo sapiens, Mus musculus
V30PPIRPIGRGAC1Arabidopsis thaliana
V38GAYGSVCSAYD2Homo sapiens, Mus musculus
V38GACGIVCSAVD1Arabidopsis thaliana
V52RQKVAVKKLSR2Homo sapiens, Mus musculus
V52NEKVAIKKITQ1Arabidopsis thaliana
V83LKHENVIGLLD2Homo sapiens, Mus musculus
V83FDHENIVAIRD1Arabidopsis thaliana
Y35VGSGAYGSVCS2Homo sapiens, Mus musculus
Y35IGRGACGIVCS1Arabidopsis thaliana


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas